Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies

Detalles Bibliográficos
Autores principales: Hu, Jie, Peng, Pai, Wang, Kai, Fang, Liang, Luo, Fei-yang, Jin, Ai-shun, Liu, Bei-zhong, Tang, Ni, Huang, Ai-long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905196/
https://www.ncbi.nlm.nih.gov/pubmed/33633321
http://dx.doi.org/10.1038/s41423-021-00648-1
_version_ 1783655063945740288
author Hu, Jie
Peng, Pai
Wang, Kai
Fang, Liang
Luo, Fei-yang
Jin, Ai-shun
Liu, Bei-zhong
Tang, Ni
Huang, Ai-long
author_facet Hu, Jie
Peng, Pai
Wang, Kai
Fang, Liang
Luo, Fei-yang
Jin, Ai-shun
Liu, Bei-zhong
Tang, Ni
Huang, Ai-long
author_sort Hu, Jie
collection PubMed
description
format Online
Article
Text
id pubmed-7905196
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79051962021-02-25 Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies Hu, Jie Peng, Pai Wang, Kai Fang, Liang Luo, Fei-yang Jin, Ai-shun Liu, Bei-zhong Tang, Ni Huang, Ai-long Cell Mol Immunol Correspondence Nature Publishing Group UK 2021-02-25 2021-04 /pmc/articles/PMC7905196/ /pubmed/33633321 http://dx.doi.org/10.1038/s41423-021-00648-1 Text en © The Author(s), under exclusive licence to CSI and USTC 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Hu, Jie
Peng, Pai
Wang, Kai
Fang, Liang
Luo, Fei-yang
Jin, Ai-shun
Liu, Bei-zhong
Tang, Ni
Huang, Ai-long
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
title Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
title_full Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
title_fullStr Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
title_full_unstemmed Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
title_short Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
title_sort emerging sars-cov-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905196/
https://www.ncbi.nlm.nih.gov/pubmed/33633321
http://dx.doi.org/10.1038/s41423-021-00648-1
work_keys_str_mv AT hujie emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT pengpai emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT wangkai emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT fangliang emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT luofeiyang emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT jinaishun emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT liubeizhong emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT tangni emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies
AT huangailong emergingsarscov2variantsreduceneutralizationsensitivitytoconvalescentseraandmonoclonalantibodies

Ejemplares similares